1. Home
  2. PMN vs STIM Comparison

PMN vs STIM Comparison

Compare PMN & STIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PMN
  • STIM
  • Stock Information
  • Founded
  • PMN 2004
  • STIM 2003
  • Country
  • PMN Canada
  • STIM United States
  • Employees
  • PMN N/A
  • STIM 201
  • Industry
  • PMN Pharmaceuticals and Biotechnology
  • STIM Medical/Dental Instruments
  • Sector
  • PMN Health Care
  • STIM Health Care
  • Exchange
  • PMN Nasdaq
  • STIM Nasdaq
  • Market Cap
  • PMN 32.3M
  • STIM 90.3M
  • IPO Year
  • PMN N/A
  • STIM 2018
  • Fundamental
  • Price
  • PMN $0.92
  • STIM $1.38
  • Analyst Decision
  • PMN
  • STIM Buy
  • Analyst Count
  • PMN 0
  • STIM 4
  • Target Price
  • PMN N/A
  • STIM $4.67
  • AVG Volume (30 Days)
  • PMN 80.8K
  • STIM 256.8K
  • Earning Date
  • PMN 12-31-2024
  • STIM 11-12-2024
  • Dividend Yield
  • PMN N/A
  • STIM N/A
  • EPS Growth
  • PMN N/A
  • STIM N/A
  • EPS
  • PMN N/A
  • STIM N/A
  • Revenue
  • PMN N/A
  • STIM $72,711,000.00
  • Revenue This Year
  • PMN N/A
  • STIM $1.97
  • Revenue Next Year
  • PMN N/A
  • STIM $7.96
  • P/E Ratio
  • PMN N/A
  • STIM N/A
  • Revenue Growth
  • PMN N/A
  • STIM 5.03
  • 52 Week Low
  • PMN $0.87
  • STIM $0.52
  • 52 Week High
  • PMN $3.10
  • STIM $5.07
  • Technical
  • Relative Strength Index (RSI)
  • PMN 45.09
  • STIM 64.78
  • Support Level
  • PMN $0.87
  • STIM $1.23
  • Resistance Level
  • PMN $0.94
  • STIM $1.58
  • Average True Range (ATR)
  • PMN 0.07
  • STIM 0.15
  • MACD
  • PMN -0.00
  • STIM 0.02
  • Stochastic Oscillator
  • PMN 31.31
  • STIM 67.18

About PMN ProMIS Neurosciences Inc. (ON)

ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA). Its proprietary target discovery engine is based on the use of two complementary techniques. The company applies its thermodynamic, computational discovery platform-ProMIS and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins.

About STIM Neuronetics Inc.

Neuronetics Inc a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulations, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advanced Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address many of the key limitations of existing treatment options.

Share on Social Networks: